Quick answer
What is parkinson's disease?
Parkinson's disease is a progressive neurological condition caused by loss of dopamine-producing cells in the brain — causing tremor (often resting), slowness of movement (bradykinesia), muscle stiffness, and balance problems. Usually develops after age 60 but young-onset occurs. No cure but levodopa and other medicines control symptoms for years. Physiotherapy, speech therapy, and exercise help. See a GP if you notice persistent tremor, smaller handwriting, or difficulty starting movements.
Parkinson’s disease — dopamine deficiency movement disorder
Parkinson’s disease (PD) is progressive neurodegeneration of dopaminergic neurons in substantia nigra — motor circuit dysfunction — tremor, bradykinesia, rigidity, postural instability.
~145,000 UK — incidence rising with ageing population.
Average onset ~60 — young-onset <50 — 10% — often genetic.
Cardinal motor features
TRAP:
- Tremor — 4–6 Hz, resting, pill-rolling, asymmetric onset
- Rigidity — cogwheel
- Akinesia/bradykinesia — slowness, reduced amplitude — most disabling
- Postural instability — later — falls
Gait: shuffling, festination, freezing
Non-motor symptoms (often earlier)
- anosmia — loss of smell
- constipation
- REM sleep behaviour disorder — act out dreams
- depression, anxiety
- cognitive decline — PD dementia later
- autonomic — orthostatic hypotension, urinary urgency
Diagnosis
Clinical — neurologist — UK Parkinson’s Disease Society Brain Bank criteria
DaTscan SPECT — if uncertain — not routine
Exclude:
- drug-induced parkinsonism — antipsychotics, metoclopramide
- vascular parkinsonism
- essential tremor — action tremor, no bradykinesia
- progressive supranuclear palsy, MSA — atypical parkinsonism — poor levodopa response
Treatment
Medicines
Levodopa + carbidopa — gold standard — best motor control
Dopamine agonists — ropinirole, pramipexole — younger onset — delay levodopa — impulse control disorder risk
MAO-B inhibitors — selegiline, rasagiline — mild early benefit
COMT inhibitors — entacapone — wearing off
Anticholinergics — rare now — tremor — cognitive side effects
Advanced
Apomorphine — rescue injection/infusion
Duodopa — intestinal gel
DBS — subthalamic nucleus/globus pallidus — motor fluctuations, dyskinesia
Non-drug
Physiotherapy, speech and language, occupational therapy
Exercise — forced rate cycling, LSVT BIG/LOUD
Motor complications (chronic levodopa)
- wearing off
- on-off fluctuations
- dyskinesias — involuntary movements
Specialist titration — fractionate doses, agonist, DBS
Prognosis
Progressive — individual rates vary
Not Alzheimer’s — many independent years
Advanced — dysphagia, falls, dementia — palliative input
Persistent one-hand rest tremor + slowness — neurology — levodopa trial diagnostic and therapeutic.
Common questions
- What are the early signs of Parkinson's disease?
- Tremor at rest — often one hand — slowness doing buttons or walking, reduced facial expression, softer voice, smaller handwriting, stiffness, shuffling gait, reduced arm swing when walking. Loss of smell and constipation can precede diagnosis by years.
- What causes Parkinson's disease?
- Loss of substantia nigra dopamine neurons and Lewy body protein deposits — cause multifactorial — age, genetics (minority familial), environmental factors debated. Not contagious. Parkinsonism from drugs (antipsychotics) or vascular causes — different management — exclude.
- Is there a cure for Parkinson's?
- No cure — medicines replace dopamine (levodopa) or mimic/stabilise it (dopamine agonists, MAO-B inhibitors). Deep brain stimulation for selected patients with motor fluctuations. Research into disease modification ongoing — exercise and multidisciplinary care improve quality of life.
- What is levodopa?
- Most effective Parkinson's drug — converted to dopamine in brain — combined with carbidopa to reduce peripheral side effects. Sinemet brand common. Motor complications — wearing off, dyskinesias — after 5–10 years — managed by specialist dose adjustment, agonists, or DBS.
- How long can you live with Parkinson's?
- Normal or near-normal lifespan — Parkinson's not directly fatal — complications — falls, aspiration pneumonia, frailty — contribute in advanced disease. Many live well 15–20 years after diagnosis with treatment and support.